CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their practice. Remember, at least one outcome measure must be reported, regardless of whether or not an outcome measure is included in a measure set.
|Quality Id||Measure Name||High Priority||Measure Type||Measure Description|
|076||2022 Measure # 076 Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections||yes||Process||Percentage of patients, regardless of age, who undergo central venous catheter (CVC) insertion for whom CVC was inserted with all elements of maximal sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed||View|
|404||2022 Measure # 404 Anesthesiology Smoking Abstinence||yes||Intermediate Outcome||The percentage of current smokers who abstain from cigarettes prior to anesthesia on the day of elective surgery or procedure||View|
|424||2022 Measure # 424 Perioperative Temperature Management||yes||Outcome||Percentage of patients, regardless of age, who undergo surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom at least one body temperature greater than or equal to 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) was achieved within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time||View|
|430||2022 Measure # 430 Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy||yes||Process||Percentage of patients, aged 18 years and older, who undergo a procedure under an inhalational general anesthetic, AND who have three or more risk factors for post-operative nausea and vomiting (PONV), who receive combination therapy consisting of at least two prophylactic pharmacologic antiemetic agents of different classes preoperatively or intraoperatively||View|
|463||2022 Measure # 463 Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics)||yes||Process||Percentage of patients aged 3 through 17 years, who undergo a procedure under general anesthesia in which an inhalational anesthetic is used for maintenance AND who have two or more risk factors for post-operative vomiting (POV), who receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively||View|
|477||2022 Measure # 477 Multimodal Pain Management||yes||Process||Percentage of patients, aged 18 years and older, undergoing selected surgical procedures that were managed with multimodal pain medicine||View|
Stay up to date with the latest news regarding MACRA and MIPS.
The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.